Basic parameters of evaluation of the effectiveness of antibiotic therapy
Article Sidebar
Published:
Dec 29, 2017
Keywords:
evolution of the effectivness of antibiotic therapy, pharmacokinetics, antibiotics
Main Article Content
Abstract
The aim of this publication is to present, in a synthetic form, the main parameters of evaluation of the effectiveness of antibiotic therapy.
Downloads
Download data is not yet available.
Article Details
How to Cite
1.
Prost ME, Prost R. Basic parameters of evaluation of the effectiveness of antibiotic therapy. Ophthatherapy [Internet]. 2017Dec.29 [cited 2024Apr.27];4(4):233-6. Available from: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/583
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
1. Blondeau JM, Hansen G, Metzler K et al. The role of PK/PD parameters to avoid selection and increase of resistance: mutant prevention concentration. J Chemother. 2004; 16 suppl 3: 1-19.
2. Metzler K, Hansen GM, Hedlin P et al. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Int J Antimicrob Agents. 2004; 24(2): 161-7.
3. Szałek E, Tomczak H, Smuszkiewicz P et al. Podstawowe wskaźniki PK/PD stosowane w antybiotykoterapii. Anestezjologia i Ratownictwo. 2009; 3: 88-93.
4. Scaglione F. Can PK/PD be used in everyday clinical practice? Int J Antimicrob Agents. 2002; 19(4): 349-53.
5. Jacobs MR. How can we predict bacterial eradication? Int J Infect Dis. 2003; 7 Suppl 1: S13-20.
6. Mouton JW, Dudley MN, Cars O et al. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother. 2005; 55: 601-7.
2. Metzler K, Hansen GM, Hedlin P et al. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Int J Antimicrob Agents. 2004; 24(2): 161-7.
3. Szałek E, Tomczak H, Smuszkiewicz P et al. Podstawowe wskaźniki PK/PD stosowane w antybiotykoterapii. Anestezjologia i Ratownictwo. 2009; 3: 88-93.
4. Scaglione F. Can PK/PD be used in everyday clinical practice? Int J Antimicrob Agents. 2002; 19(4): 349-53.
5. Jacobs MR. How can we predict bacterial eradication? Int J Infect Dis. 2003; 7 Suppl 1: S13-20.
6. Mouton JW, Dudley MN, Cars O et al. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother. 2005; 55: 601-7.